Apigenin Prevents Acetaminophen-Induced Liver Injury by Activating the SIRT1 Pathway
Copyright © 2020 Zhao, Zhang, Hu, Wang, Lu, Wu, Chen, Jin, Ji, Cao and Jiang..
Acetaminophen (APAP) overdose is the main cause of acute liver failure. Apigenin (API) is a natural dietary flavonol with high antioxidant capacity. Herein, we investigated protection by API against APAP-induced liver injury in mice, and explored the potential mechanism. Cell viability assays and mice were used to evaluate the effects of API against APAP-induced liver injury. Western blotting, immunofluorescence staining, RT-PCR, and Transmission Electron Microscope were carried out to determine the signalling pathways affected by API. Analysis of mouse serum levels of alanine/aspartate aminotransferase (ALT/AST), malondialdehyde (MDA), liver myeloperoxidase (MPO) activity, glutathione (GSH), and reactive oxygen species (ROS) revealed that API (80 mg/kg) owned protective effect on APAP-induced liver injury. Meanwhile, API ameliorated the decreased cell viability in L-02 cells incubated by APAP with a dose dependent. Furthermore, API promoted SIRT1 expression and deacetylated p53. Western blotting showed that API promoted APAP-induced autophagy, activated the NRF2 pathway, and inhibited the transcriptional activation of nuclear p65 in the presence of APAP. Furthermore, SIRT1 inhibitor EX-527 reduced protection by API against APAP-induced hepatotoxicity. Molecular docking results indicate potential interaction between API and SIRT1. API prevents APAP-induced liver injury by regulating the SIRT1-p53 axis, thereby promoting APAP-induced autophagy and ameliorating APAP-induced inflammatory responses and oxidative stress injury.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Frontiers in pharmacology - 11(2020) vom: 08., Seite 514 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhao, Licong [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acetaminophen-induced liver injury |
---|
Anmerkungen: |
Date Revised 28.09.2020 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3389/fphar.2020.00514 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM310083109 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM310083109 | ||
003 | DE-627 | ||
005 | 20231225135325.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fphar.2020.00514 |2 doi | |
028 | 5 | 2 | |a pubmed24n1033.xml |
035 | |a (DE-627)NLM310083109 | ||
035 | |a (NLM)32425778 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhao, Licong |e verfasserin |4 aut | |
245 | 1 | 0 | |a Apigenin Prevents Acetaminophen-Induced Liver Injury by Activating the SIRT1 Pathway |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 28.09.2020 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2020 Zhao, Zhang, Hu, Wang, Lu, Wu, Chen, Jin, Ji, Cao and Jiang. | ||
520 | |a Acetaminophen (APAP) overdose is the main cause of acute liver failure. Apigenin (API) is a natural dietary flavonol with high antioxidant capacity. Herein, we investigated protection by API against APAP-induced liver injury in mice, and explored the potential mechanism. Cell viability assays and mice were used to evaluate the effects of API against APAP-induced liver injury. Western blotting, immunofluorescence staining, RT-PCR, and Transmission Electron Microscope were carried out to determine the signalling pathways affected by API. Analysis of mouse serum levels of alanine/aspartate aminotransferase (ALT/AST), malondialdehyde (MDA), liver myeloperoxidase (MPO) activity, glutathione (GSH), and reactive oxygen species (ROS) revealed that API (80 mg/kg) owned protective effect on APAP-induced liver injury. Meanwhile, API ameliorated the decreased cell viability in L-02 cells incubated by APAP with a dose dependent. Furthermore, API promoted SIRT1 expression and deacetylated p53. Western blotting showed that API promoted APAP-induced autophagy, activated the NRF2 pathway, and inhibited the transcriptional activation of nuclear p65 in the presence of APAP. Furthermore, SIRT1 inhibitor EX-527 reduced protection by API against APAP-induced hepatotoxicity. Molecular docking results indicate potential interaction between API and SIRT1. API prevents APAP-induced liver injury by regulating the SIRT1-p53 axis, thereby promoting APAP-induced autophagy and ameliorating APAP-induced inflammatory responses and oxidative stress injury | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a SIRT1 pathway | |
650 | 4 | |a SIRT1-p53 axis | |
650 | 4 | |a acetaminophen-induced liver injury | |
650 | 4 | |a antioxidant | |
650 | 4 | |a apigenin | |
650 | 4 | |a flavonol | |
650 | 4 | |a inflammatory response | |
650 | 4 | |a oxidative stress | |
700 | 1 | |a Zhang, Jiaqi |e verfasserin |4 aut | |
700 | 1 | |a Hu, Cheng |e verfasserin |4 aut | |
700 | 1 | |a Wang, Tao |e verfasserin |4 aut | |
700 | 1 | |a Lu, Juan |e verfasserin |4 aut | |
700 | 1 | |a Wu, Chenqu |e verfasserin |4 aut | |
700 | 1 | |a Chen, Long |e verfasserin |4 aut | |
700 | 1 | |a Jin, Mingming |e verfasserin |4 aut | |
700 | 1 | |a Ji, Guang |e verfasserin |4 aut | |
700 | 1 | |a Cao, Qin |e verfasserin |4 aut | |
700 | 1 | |a Jiang, Yuanye |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in pharmacology |d 2010 |g 11(2020) vom: 08., Seite 514 |w (DE-627)NLM208568891 |x 1663-9812 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2020 |g day:08 |g pages:514 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fphar.2020.00514 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2020 |b 08 |h 514 |